This summary was created by AI, based on 1 opinions in the last 12 months.
CDZ-T is a low MER Canadian Dividend Aristocrats ETF with over 90 holdings, all of which have consistently increased their dividends over the past five years. The portfolio has an average PE of 16x earnings and has averaged a 7.4% annual return since inception. Experts recommend setting a stop loss at $31 and looking to achieve $44, with an 18% upside potential. The ETF also offers a 3.6% yield, making it an attractive option for investors seeking income and long-term growth.
Likes XEI for dividends. Lots of large-cap banks and pipelines.
CDZ has more mid-caps than the large caps that XEI has. Includes names like KEY, CSH.UN, GWO and ARE. More diversification, but more beta. Yield is 3.8%, not bad. Could complement XEI, but you may want to look at US or global dividend strategies for more diversification.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The fund holds companies that have increased their dividends for at least 5 years in a row. They also screen for quality of balance sheet and earnings and holds established large-cap names. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The ETF focuses on good dividend payers and offers good yield with a strong track record. It strategically covers multiple sectors including financials, utilities, energy and real estate. Unlock Premium - Try 5i Free
He was buying it for diversification--it's not only about banks. There's nothing wrong with this. This ETF is about dividends as well as growth.
Dividend investing is a long term factor strategy and this is one of the granddaddies in the sector. To be classed as Aristocrat, dividends have to have been steady or rising for 5 years in Canada and 25 years in the US holdings. Its fee is a little higher than new products. ZEI-T is perhaps another alternative with a lower fee.
A leftover from Claymore. Not as high quality. Somebody called it the proletarian as opposed to aristocrats. It is diverse. Perfectly acceptable ETF.
It is one of the earliest ETFs in Canada. There are others now with better pricing. A payout fall could only reflect a fall in the underlying sectaries’ payout.
A leftover from Claymore’s ETF’s. It’s a lesser quality ETF compared to the ZDV in terms of the stocks it holds. Doesn’t see anything wrong with holding it.
Largely a lot of companies that you haven’t heard of. He is not thrilled with this and would rather do one of the dividend plays that have more large caps such as iShares S&P/TSX Equity Income (XEI-T) or iShares Cdn Div (XDV-T).
Has been using the XEI-T instead of this. This has a fairly large energy component. It is a perfectly good dividend paying ETF.
TFSA means “Totally For Speculation Account.” Buying uranium ETF for long hold is probably great. Thinks we are seeing a bottom in uranium. It could be a triple, or maybe 10 times.
iShares Cdn Div Aristocrats ETF is a Canadian stock, trading under the symbol CDZ-T on the Toronto Stock Exchange (CDZ-CT). It is usually referred to as TSX:CDZ or CDZ-T
In the last year, there was no coverage of iShares Cdn Div Aristocrats ETF published on Stockchase.
iShares Cdn Div Aristocrats ETF was recommended as a Top Pick by on . Read the latest stock experts ratings for iShares Cdn Div Aristocrats ETF.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered iShares Cdn Div Aristocrats ETF In the last year. It is a trending stock that is worth watching.
On 2024-12-11, iShares Cdn Div Aristocrats ETF (CDZ-T) stock closed at a price of $36.83.
CDZ is a low MER (0.6%) ETF of Canadian dividend aristocrat stocks -- over 90 holdings that have increased their dividends consistently over the past five years. The average PE of the portfolio is 16x earnings. Since inception it has averaged a 7.4% annual return. We recommend setting a stop loss at $31, looking to achieve $44 -- upside potential of 18%. Yield 3.6%